higher binding and also it was more readily available.
Dextran coated charcoal suspension
This was prepared by mixing equal volumes of an aqueous suspension of charcoal, Ig/IOO ml (Norit A, Sigma Chemical Company), and an aqueous solution of Dextran T 70 O.lg/l00ml (Pharmacia), The suspension was prepared just before use and continually stirred during pipetting.
Isotope counting
Radioactivity was counted using a Packard Tricarb liquid scintillation counter. The scintillator fluid was toluene-triton X 100 (2:1) containing 0.6 % butyl PBD (2-(4'-tert-butylphenyl)-5-(4" biphenylyl)-1, 3, 4-oxadiazole).
Sample extraction and purification
Binding protein-isotope reagent 1,2-3H-Cortisol and 6,7-3H-prednisolone (specific activities 45 and 47 Ci/rnrnol respectively) were obtained from Radiochemical Centre, Amersham, England. They were dissolved in ethanol to give a final working solution of 10 JLCi/mland stored at 4°. Radiochemical purity was checked by thinlayer chromatography (T.L.C.) on silica gel using methylene dichloride-methanol-water (150: 10; 1) as developer. Cortisol and prednisolone were purchased from Sigma Chemical Company.
All other steroids were purchased from Steraloids Ltd. All steroid solutions were made up in ethanol to contain 1 mg/rnl and stored at 4 0. Tablets, each containing 5 mg of prednisolone (Roussel Laboratories), were used for human studies.
MATERIALS AND METHODS
Plasma (2 ml) was extracted twice with 5 ml ethyl acetate; the extracts combined and evaporated to dryness at 40°under nitrogen. The residue was taken up in 0.15 ml absolute ethanol and 0.05 ml samples chromatographed in duplicate alongside a prednisolone marker (15 JLg) on a previously activated (70°, 30 min), silica gel sheet containing fluorescent indicator (Chromagram 6060; Eastman Kodak). The solvent system used for development was methylene dichloride-methanol-water, 150: 10: 1. Each chromagram sheet (20 x 20 ern) was divided into four lanes, one lane of which was spotted with ethanol (0.05 ml) to provide a 'plate-blank' value for the C.P.B. procedure. Samples were applied as a streak, 2.5 cm from the bottom of the sheet, and the chromatogram developed until the solvent front had travelled about 15 cm (approximately 60 min). The prednisolone marker was located under ultraviolet light and the corresponding areas in the sample and blank lanes were cut out and eluted twice with 2 ml acetone. The two eluates from each lane were combined and evaporated to dryness at 40°under nitrogen. The residue was dissolved in 2.1 ml of a solution of 2 ml ethanol and 98 ml aqueous sodium Both late pregnancy plasma and plasma from chloride, 0.9 g/IOOm!. 1 ml samples of this solution women on oral contraceptives were investigated. The were used in the competitive protein binding assay latter was used routinely because it gave slightly described for 'cortisol' by Pegg and Keane (1969) . 11
Steroids
Prednisolone added (ng) • Adapted from Kolanowski and Pizarro (1969) .
Preparation of standard curve
A set of standards in ethanol-saline (1 ml) containing 5, 10, 20, 30, 40 and 50 ng of prednisolone was used. Displacement of protein-bound tracer was determined according to Pegg and Keane (1969) procedure. The percentage of protein-bound radioactivity was plotted against the amount of prednisolone added (Fig. 1 ). Figure 1 shows that there was no advantage in using 3H-prednisolone instead of 3H-cortisol for preparing the binding protein-isotope reagent.
RESULTS

Standard curve
Cross reaction
Although several endogenous steroids cross react in the C.P.B. method (Kolanowski and Pizarro, 1969) T.L.C. separation eliminated all interference from this source. Blank values for water and normal but prednisolone free plasma taken through the whole procedure were identical. Prednisone did not cross react in the C.P.B. procedure and therefore could not be measured by this technique.
Recovery
Recovery of 3H-prednisolone added to plasma to give concentrations within the range 15-150 nglml and processed as described in the methods section was 85 ± 1.3 % (mean ± S.D.). Subsequently all plasma assays were corrected for recovery.
Fig. I-Prednisolone standard curve,
The radioactive steroids used for preparing the standard curves were 3H-prednisolone ( -----) and 3H-cortisol ( ---).
Sensitivity
T.L.C. blanks obtained with either 2 ml of water or 2 ml of prednisolone free plasma correspond to a concentration of 6 ng/ml of prednisolone in the original sample. This value was constant over the range of sample sizes used (2-5 ml) and therefore was subtracted from all assays. The smallest concentration of prednisolone in the plasma that could be measured with confidence (p < 0.01) was 15 ng/rnl,
Precision
Between-batch precision was determined by assaying three pools of plasma (1-3) containing prednisolone added to give a final concentration of IS, 75 and 150 ng/ml of plasma respectively. The results are given in Table 2 and show an acceptable coefficient of variation.
Storage
Plasma samples were stored frozen for periods up to three weeks and assayed for prednisolone at various intervals. Results given in Table 3 show that the assay was not affected by storage.
Plasma prednisolone concentration
Six normal male adult volunteers, aged 23-28 years participated in this study. Each subject was given an oral dose of 15 mg prednisolone after an overnight fast. Blood was collected before and at I, Table 2 Precision of the plasma prednisolone assay
The number of determinations are given in parentheses. Known amounts of prednisolone were added to plasma and 2 ml aliquots were processed according to the method described in the text. 2, 3, 4 and 5 h after administration of the dose. Plasma was separated immediately and stored frozen until assayed. Results are shown in Fig. 1. zoo Time after admlni.traticn (hr) Fig. I-Plasma prednfsolone levels in six nonnal subjects (A-F), following a single dose (15 mg) of prednisolone given orally.
Amount of prednisolone
Details of blood sample collection and prednisolone assay method have been described in tbe text; -represents mean values of the plasma concentrations in four subjects (A-D).
In four of the six subjects (A-D) plasma prednisolone concentration followed a similar pattern. Maximum values (126.8 ± 12 ng/rnl) were reached within 1 h of ingesting the tablets. Thereafter a plot of log plasma levels against time yielded a straight line from which the plasma half-life (tt) of prednisolone could be calculated to be 2 h 29 min. ± 5 min.
Two subjects (E and F) showed delayed prednisolone absorption (Fig. 2) and calculation of plasma half-life was not possible from the data obtained.
DISCUSSION
The observations reported here permit the conclusion that the present method is sufficiently sensitive and precise to be useful for measuring plasma prednisolone concentration in clinical practice. It is simple enough to be practicable for routine use and since 3H-cortiso\ is as effective as 3H-prednisolone for preparing the binding protein-isotope reagent (Fig. 1) its introduction into laboratories already using a C.P.B. method for plasma cortisol can be accomplished without extra cost for radiochemicals In our experience, one person can analyse 24 plasma samples a day. Preliminary investigations indicate that the method can also be applied to the measurement of urinary prednisolone.
The method is not sufficiently sensitive to permit satisfactory measurements of plasma prednisolone concentrations below 15 ng/ml, Moreover, although it is desirable to determine the 'T.L.e. blank' for each run, we found that two batches of 'Chromagram' T.L.e. sheets, used without prior washing, gave identical results which did not differ significantly from those obtained using plasma from 10 normal subjects. This provides indirect confirmation that the T.L.e. step used eliminates interference from endogenous substances capable of cross reacting with prednisolone in the e.P.B. method.
Mean prednisolone plasma half-life of 149 min. in four subjects in the present study is similar to that of 168 min. calculated from the data presented by Ely et al., (1966) but considerably shorter than that (ca. 280 min.) reported by Jenkins and Sampson (1967) . Both of these groups of workers determined plasma 17, 21-dihydroxy corticosteroid after administration of 45 and 100 mg of prednisolone respectively.
